The House Appropriation Committee has voted to uphold a ban on genetically modified babies; an assisted suicide bill was passed by the Maine Legislature and will head to the desk of Governor Janet Mills; Beverly Hills has become the first city in the United States to ban sales of tobacco and tobacco-related products.
The House Appropriations Committee voted yesterday to continue a federal ban on creating genetically modified babies in the United States, NPR reported. The vote was included in a debate over routine funding for the FDA and prohibits the agency from considering any proposals to try to use genetically modified embryos to establish pregnancies. The ban is opposed by some scientists because it prevents them from conducting studies that could determine the safety of creating genetically modified babies as a way to prevent genetic diseases. Several Democratic committee members said they reluctantly supported the ban but hope it will be reconsidered in the future.The Maine Legislature voted yesterday to legalize assisted suicide, which would allow physicians to prescribe fatal doses of medication to terminally ill patients, according to The New York Times. The bill, which had failed once before in a statewide vote at least 7 previous times in the Legislature, will now head to governor's desk. Governor Janet Mills has not yet expressed support or opposition for letting it become a law.Beverly Hills, California, has become the first city in the United States to end most tobacco sales after the City Council unanimously voted yesterday to ban the sale of cigarettes, cigars, and e-cigarettes starting in 2021, the Los Angeles Times reported. The ban will prohibit convenience stores, gas stations, pharmacies, and grocery stores from selling tobacco and tobacco-related products but will still allow hotels and cigar lounges to sell them. While business owners have opposed the measure, public health advocates have argued the cost is higher in terms of health.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More